Cargando…
DDRE-31. FEASIBILITY AND BIOLOGIC ACTIVITY OF A KETOGENIC / INTERMITTENT FASTING DIET IN GLIOMA PATIENTS
BACKGROUND: There has been increasing interest in exploring ketogenic diet therapies (KDT) in patients with glioma given the poor prognosis. The purpose of this single-arm, open label phase 2 study was to rigorously examine the feasibility, safety, systemic biological activity, and cerebral activity...
Autores principales: | Schreck, Karisa, Hsu, Fang-Chi, Berrington, Adam, Henry-Barron, Bobbie, Vizthum, Diane, Blair, Lindsay, Kossoff, Eric, Easter, Linda, Whitlow, Christopher, Cervenka, Mackenzie, Barker, Peter, Blakeley, Jaishri, Strowd, Roy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992260/ http://dx.doi.org/10.1093/noajnl/vdab024.053 |
Ejemplares similares
-
BIMG-23. SINGLE-VOXEL VERSUS MULTI-SLICE MRSI IN PATIENTS WITH GLIOMA ON A KETOGENIC DIET INTERVENTION
por: Munjapara, Vasu, et al.
Publicado: (2021) -
Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations
por: Kossoff, Eric H., et al.
Publicado: (2020) -
Ketogenic Dietary Therapy Controversies for Its Second
Century
por: Kossoff, Eric, et al.
Publicado: (2019) -
DDRE-34. TARGETING RESISTANCE IN MEDULLOBLASTOMA
por: Chang, Simone, et al.
Publicado: (2021) -
Is there a role for diet monotherapy in adult epilepsy?
por: Cervenka, Mackenzie C., et al.
Publicado: (2016)